We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont MemCor MBR Selected for Riverstone Upgrade in Australia
Read MoreHide Full Article
Key Takeaways
DuPont's MemCor MBR tech was selected for the next upgrade phase at Sydney's Riverstone WRRF.
The MemCor system includes 2,592 MemPulse B50 modules for a 24.8 ML/day average capacity and 86 ML/day peak.
The upgrade is part of North West expansion to boost treatment, protect waterways and support housing.
DuPont de Nemours, Inc. (DD - Free Report) recently announced that its MemCor membrane bioreactor (MBR) system has been selected for the next phase of upgrades at the Riverstone Water Resource Recovery Facility (WRRF) in Sydney, Australia. This significant investment in wastewater infrastructure is aimed at supporting the region’s population growth while enhancing environmental protection.
The upgrade will be led by the North West Hub Alliance, which includes Sydney Water, John Holland, KBR and Stantec. DuPont will supply a MemCor MBR system featuring 2,592 MemPulse B50 MBR modules, designed to support an average capacity of 24.8 megaliters per day and a peak wet weather flow of 86 megaliters per day.
The Riverstone upgrade forms a major part of a broader expansion of wastewater treatment infrastructure across Sydney’s North West region. Once complete, the upgraded facility is expected to significantly increase treatment capacity, protect waterways, and support future housing development in the region.
The project highlights the value of collaboration between utilities. The infrastructure investments and local expertise of DuPont in Australia will enable technology providers to help communities while protecting vital water resources. DuPont’s commitment to sustainable water management solutions will help purify more than 50 million gallons of water every minute in 112 countries across the world.
DD has slumped 34.1% over the past year against the industry’s 2.8% growth.
Image Source: Zacks Investment Research
For the second quarter of 2026, DuPont expects net sales of about $1.8 billion and operating EBITDA of about $430 million. Adjusted earnings are projected at approximately 59 cents per share, with guidance assuming about 3% organic sales growth year over year and currency as a slight tailwind.
Management raised its full-year 2026 outlook following the first-quarter outperformance and the interest income benefit tied to the Aramids transaction. The company now expects net sales of $7.155-$7.215 billion, operating EBITDA of $1.730-$1.760 billion and adjusted earnings of $2.35-$2.40 per share for 2026.
DD’s Zacks Rank & Key Picks
DD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , CF Industries Holdings, Inc. (CF - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 135.6% over the past year.
The Zacks Consensus Estimate for CF’s 2026 earnings is pegged at $17.16 per share, indicating a rise of 83.14% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 11.42%. CF’s shares have soared 16.5% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
DuPont MemCor MBR Selected for Riverstone Upgrade in Australia
Key Takeaways
DuPont de Nemours, Inc. (DD - Free Report) recently announced that its MemCor membrane bioreactor (MBR) system has been selected for the next phase of upgrades at the Riverstone Water Resource Recovery Facility (WRRF) in Sydney, Australia. This significant investment in wastewater infrastructure is aimed at supporting the region’s population growth while enhancing environmental protection.
The upgrade will be led by the North West Hub Alliance, which includes Sydney Water, John Holland, KBR and Stantec. DuPont will supply a MemCor MBR system featuring 2,592 MemPulse B50 MBR modules, designed to support an average capacity of 24.8 megaliters per day and a peak wet weather flow of 86 megaliters per day.
The Riverstone upgrade forms a major part of a broader expansion of wastewater treatment infrastructure across Sydney’s North West region. Once complete, the upgraded facility is expected to significantly increase treatment capacity, protect waterways, and support future housing development in the region.
The project highlights the value of collaboration between utilities. The infrastructure investments and local expertise of DuPont in Australia will enable technology providers to help communities while protecting vital water resources. DuPont’s commitment to sustainable water management solutions will help purify more than 50 million gallons of water every minute in 112 countries across the world.
DD has slumped 34.1% over the past year against the industry’s 2.8% growth.
Image Source: Zacks Investment Research
For the second quarter of 2026, DuPont expects net sales of about $1.8 billion and operating EBITDA of about $430 million. Adjusted earnings are projected at approximately 59 cents per share, with guidance assuming about 3% organic sales growth year over year and currency as a slight tailwind.
Management raised its full-year 2026 outlook following the first-quarter outperformance and the interest income benefit tied to the Aramids transaction. The company now expects net sales of $7.155-$7.215 billion, operating EBITDA of $1.730-$1.760 billion and adjusted earnings of $2.35-$2.40 per share for 2026.
DD’s Zacks Rank & Key Picks
DD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , CF Industries Holdings, Inc. (CF - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB sports a Zacks Rank #1 (Strong Buy) at present, CF and ASM carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 135.6% over the past year.
The Zacks Consensus Estimate for CF’s 2026 earnings is pegged at $17.16 per share, indicating a rise of 83.14% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 11.42%. CF’s shares have soared 16.5% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.